Resonance Specialities last traded at ₹180.00 (2026-10-13). Over the past month the stock moved +5.3%, three months the stock moved +43.0%, year the stock moved +74.8%. Its closing range over 52 weeks is ₹83.69 – ₹197.75, with the latest close 9.0% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same[1]
Business Overview:[1] The Company manufactures and markets pyridine, pyridine derivatives, picolines, and bulk drugs, with pyridine and its derivatives constituting its primary source of revenue.
In the latest quarter (Jun 2026), Resonance Specialities reported sales of ₹32.58 crore (+53.2%) and net profit of ₹5.74 crore (+252.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 32.58 | 7.46 | 22.90 | 5.74 | 4.97 |
| Mar 2026 | 24.48 | 5.64 | 23.04 | 4.60 | 3.98 |
| Dec 2025 | 22.96 | 3.45 | 15.03 | 2.51 | 2.17 |
| Sep 2025 | 21.53 | 2.36 | 10.96 | 1.66 | 1.44 |
| Jun 2025 | 21.27 | 2.55 | 11.99 | 1.63 | 1.41 |
| Mar 2025 | 24.20 | 4.25 | 17.56 | 3.06 | 2.65 |
| Dec 2024 | 18.24 | 1.89 | 10.36 | 1.12 | 0.97 |
| Sep 2024 | 18.06 | 2.35 | 13.01 | 1.81 | 1.57 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +78.1% | +18.9% | +47.9% | +22.9% | +19.2% | +25.9% | +1.2% | +53.2% |
| Operating profit growth | +155.4% | +43.2% | +304.8% | +22.6% | +0.4% | +82.5% | +32.7% | +192.5% |
| Net profit growth | +293.5% | +16.7% | +356.7% | +176.3% | -8.3% | +124.1% | +50.3% | +252.1% |
| EPS growth | +292.5% | +16.9% | +356.9% | +176.5% | -8.3% | +123.7% | +50.2% | +252.5% |
| OPM % | 13.0% | 10.4% | 17.6% | 12.0% | 11.0% | 15.0% | 23.0% | 22.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Resonance Specialities reported sales of ₹90.00 crore (+15.7%) and net profit of ₹10.00 crore (+52.2%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 90.00 | 14.00 | 16.00 | 10.00 | 9.01 |
| Mar 2025 | 77.81 | 10.78 | 13.85 | 6.57 | 5.69 |
| Mar 2024 | 54.82 | 4.82 | 8.79 | 2.97 | 2.57 |
| Mar 2023 | 57.98 | 6.83 | 11.78 | 5.00 | 4.33 |
| Mar 2022 | 75.76 | 16.75 | 22.11 | 12.36 | 10.71 |
| Mar 2021 | 70.29 | 14.25 | 20.27 | 10.52 | 9.11 |
| Mar 2020 | 56.14 | 7.75 | 13.80 | 5.51 | 4.77 |
| Mar 2019 | 41.40 | 4.89 | 11.81 | 3.20 | 2.77 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +15.9% | +35.6% | +25.2% | +7.8% | -23.5% | -5.5% | +41.9% | +15.7% |
| Operating profit growth | +652.3% | +58.5% | +83.9% | +17.5% | -59.2% | -29.4% | +123.7% | +29.9% |
| Net profit growth | – | +72.2% | +90.9% | +17.5% | -59.5% | -40.6% | +121.2% | +52.2% |
| EPS growth | – | +72.2% | +91.0% | +17.6% | -59.6% | -40.6% | +121.4% | +58.3% |
| OPM % | 11.8% | 13.8% | 20.3% | 22.1% | 11.8% | 8.8% | 13.9% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Resonance Specialities.
Get Free AI Stock Analysis FREE →Resonance Specialities standalone net profit rises 252.15% in the June 2026 quarter - Business Standard
Resonance Specialities shares were last quoted at ₹180.00 (+2.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Resonance Specialities has a price-to-earnings (P/E) ratio of 15.25 and a price-to-book (P/B) ratio of 2.80. The industry P/E is 43.03.
The 52-week high of Resonance Specialities is ₹191.75 and the 52-week low is ₹77.00.
The market capitalisation of Resonance Specialities is about ₹221.36 crore.
In the latest quarter (Jun 2026), Resonance Specialities reported sales of ₹32.58 crore (+53.2%) and net profit of ₹5.74 crore (+252.1%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Resonance Specialities has a 3-year ROE of 11.00%, 3-year profit growth of 27.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 54.25% of Resonance Specialities.
Resonance Specialities belongs to the Chemicals sector.